سعر هورمستون 10 مجم 20 قرص 2022

Dydrogesterone 10 mg tablets (Hormston, CID / Chemipharm, Egypt), an oral progestogen; pack of 20 tablets.

• Conditions associated with progesterone insufficiency: dysmenorrhoea, endometriosis, infertility, irregular menstrual cycles and pre-menstrual syndrome.medicines.ie (HPRA-approved product information, Ireland)
• With an estrogen: dysfunctional uterine bleeding, secondary amenorrhoea, and as the progestogen component of hormone replacement therapy.medicines.ie (HPRA-approved product information, Ireland)

• Most commonly reported (without estrogen): migraine/headache, nausea, menstrual disorders and breast pain/tenderness; uncommon: depressed mood, dizziness, vomiting, abnormal hepatic function, allergic dermatitis; rare: increase in size of progestogen-dependent neoplasms (e.g. meningioma), haemolytic anaemia, hypersensitivity, angioedema.International label, equivalent formulation · medicines.ie (HPRA-approved product information, Ireland)

• Known hypersensitivity to dydrogesterone or any excipient.International label, equivalent formulation · medicines.ie (HPRA-approved product information, Ireland)
• Known or suspected progestogen-dependent neoplasms; meningioma or history of meningioma.International label, equivalent formulation · medicines.ie (HPRA-approved product information, Ireland)
• Undiagnosed abnormal vaginal bleeding.International label, equivalent formulation · medicines.ie (HPRA-approved product information, Ireland)

• Clarify the aetiology of abnormal bleeding before treatment; investigate breakthrough bleeding that appears after some time on therapy or persists after stopping (may include endometrial biopsy).International label, equivalent formulation · medicines.ie (HPRA-approved product information, Ireland)
• Alterations in liver function have been reported infrequently; use with caution in acute or past liver disease and stop in severe hepatic impairment.International label, equivalent formulation · medicines.ie (HPRA-approved product information, Ireland)
• Meningiomas have been reported; monitor for signs and stop treatment if meningioma is diagnosed.International label, equivalent formulation · medicines.ie (HPRA-approved product information, Ireland)

• CYP inducers (e.g. phenobarbital, phenytoin, carbamazepine, rifampicin, rifabutin, nevirapine, efavirenz, St John's wort, sage, ginkgo; ritonavir and nelfinavir with steroid hormones)May increase the metabolism of dydrogesterone and its active metabolite (CYP3A4), possibly decreasing its effect.medicines.ie (HPRA-approved product information, Ireland)

• More than 10 million pregnancies are estimated to have been exposed to dydrogesterone with no indication of harm so far; a possible hypospadias risk reported with some progestogens cannot be definitively assessed. Can be used in pregnancy if clearly indicated.International label, equivalent formulation · medicines.ie (HPRA-approved product information, Ireland)
• No data on excretion in human milk; progestogens pass into milk in small quantities, so dydrogesterone should not be used during lactation.International label, equivalent formulation · medicines.ie (HPRA-approved product information, Ireland)

English text not available for this section.